Pyxis Oncology revenue was $16.15M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PYXS annual revenue was $16.1M, with Infinity% growth year-over-year.
PYXS revenue history
Current Revenue
$16.1M
Current Earnings
-$77.3M
Current Profit Margin
-478.9%
Be the first to know when PYXS announces revenue.
PYXS Revenue History By Year
PYXS Yearly Revenue
PYXS Revenue
PYXS Change
PYXS Revenue Growth
2024-12-31
$16.15M
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
2020-12-31
$0.00
N/A
N/A
2019-12-31
$0.00
N/A
N/A
1 of 1
Pyxis Oncology Revenue FAQ
What was PYXS's revenue last quarter?
Pyxis Oncology (NASDAQ: PYXS) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Pyxis Oncology's revenue was $0.00.
What was Pyxis Oncology's revenue in 2024?
Pyxis Oncology's annual revenue for the twelve months ending Dec 31, 2024 was $16.15 million, a Infinity% increase year over year.
How much does Pyxis Oncology make in a day?
Based on Pyxis Oncology annual revenue for the past five years, PYXS makes an average of $8,847.12 per day.
What was Pyxis Oncology's annual revenue growth in the past year?
As of Q2 2025, Pyxis Oncology's revenue has grown null year over year. Pyxis Oncology's revenue in the past year totaled $16.15 million.
How much does Pyxis Oncology make in a year?
Pyxis Oncology's revenue by year for the past five years is:
Pyxis Oncology's revenue for the twelve months ending Dec 31, 2024 was $16.15 million, a Infinity% increase year over year.
Pyxis Oncology's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Pyxis Oncology's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Pyxis Oncology's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Pyxis Oncology's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.